Mauz-Körholz C - Search Results

1

Risk and Response Adapted Treatment Guidelines for Managing First Relapsed and Refractory Classical Hodgkin Lymphoma in Children and Young People. Recommendations from the EuroNet Pediatric Hodgkin Lymphoma Group.

Daw S, Hasenclever D, Mascarin M, Fernández-Teijeiro A, Balwierz W, Beishuizen A, Burnelli R, Cepelova M, Claviez A, Dieckmann K, Landman-Parker J, Kluge R, Körholz D, Mauz-Körholz C, Wallace WH, Leblanc T. Daw S, et al. Hemasphere. 2020 Jan 10;4(1):e329. doi: 10.1097/HS9.0000000000000329. eCollection 2020 Feb. Hemasphere. 2020. PMID: 32072145 Free PMC article. Review.

2

Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy & Immunobiology Working Party.

Greco R, Hoogenboom JD, Bonneville EF, Anagnostopoulos A, Cuoghi A, Dalle JH, Weissinger EM, Lang P, Galaverna F, Martino M, Maschan A, Mauz-Körholz C, Noviello M, Passweg J, Peccatori J, Rovira M, Solano C, Veelken H, Velardi A, Wagner-Drouet EM, Zhang X, Ciceri F, Bonini C, Vago L, Ruggeri A, Chabannon C. Greco R, et al. Bone Marrow Transplant. 2023 May;58(5):603-606. doi: 10.1038/s41409-023-01939-z. Epub 2023 Feb 22. Bone Marrow Transplant. 2023. PMID: 36813866 Free PMC article. No abstract available.

3

Correlation of low histidine rich glycoprotein plasma levels with the occurrence of acute graft-versus-host disease after allogeneic bone marrow transplantation.

Mauz-Körholz C, Körholz D, Burdach S. Mauz-Körholz C, et al. J Lab Clin Med. 1995 Aug;126(2):144-50. J Lab Clin Med. 1995. PMID: 7636387

4

Detection of antiphospholipid antibodies in children and adolescents.

Kratz C, Mauz-Körholz C, Kruck H, Körholz D, Göbel U. Kratz C, et al. Pediatr Hematol Oncol. 1998 Jul-Aug;15(4):325-32. doi: 10.3109/08880019809014016. Pediatr Hematol Oncol. 1998. PMID: 9658433

5

Transforming growth factor-beta1 suppresses interleukin-15-mediated interferon-gamma production in human T lymphocytes.

Bönig H, Banning U, Hannen M, Kim YM, Verheyen J, Mauz-Körholz C, Körholz D. Bönig H, et al. Scand J Immunol. 1999 Dec;50(6):612-8. doi: 10.1046/j.1365-3083.1999.00635.x. Scand J Immunol. 1999. PMID: 10607309 Free article.

6

DDAVP treatment in a child with von Willebrand disease type 2M.

Mauz-Körholz C, Budde U, Körholz D, Göbel U. Mauz-Körholz C, et al. Eur J Pediatr. 1999 Dec;158 Suppl 3:S174-6. doi: 10.1007/pl00014349. Eur J Pediatr. 1999. PMID: 10650863

7

Mechanisms of hyperthermia- and 4-hydroperoxy-ifosfamide-induced cytotoxicity in T cell leukemia.

Mauz-Körholz C, Dietzsch S, Banning U, Tröbs RB, Körholz D. Mauz-Körholz C, et al. Anticancer Res. 2002 Nov-Dec;22(6C):4243-7. Anticancer Res. 2002. PMID: 12553065

8

Drug-induced caspase-3 activation in a Ewing tumor cell line and primary Ewing tumor cells.

Mauz-Körholz C, Kachel M, Harms-Schirra B, Klein-Vehne A, Tunn PU, Körholz D. Mauz-Körholz C, et al. Anticancer Res. 2004 Jan-Feb;24(1):145-9. Anticancer Res. 2004. PMID: 15015589 Free article.

9

The concept of the GPOH-HD 2003 therapy study for pediatric Hodgkin's disease: evolution in the tradition of the DAL/GPOH studies.

Körholz D, Claviez A, Hasenclever D, Kluge R, Hirsch W, Kamprad F, Dörffel W, Wickmann L, Papsdorf K, Dieckmann K, Kahn T, Mauz-Körholz C, Dannenberg C, Pötter R, Brosteanu O, Schellong G, Sabri O. Körholz D, et al. Klin Padiatr. 2004 May-Jun;216(3):150-6. doi: 10.1055/s-2004-822627. Klin Padiatr. 2004. PMID: 15175959

10

Regulation of interleukin-2 induced soluble Fas ligand release from human peripheral blood mononuclear cells.

Mauz-Körholz C, Banning U, Körholz D. Mauz-Körholz C, et al. Immunol Invest. 2004 May;33(2):251-60. doi: 10.1081/imm-120030916. Immunol Invest. 2004. PMID: 15195700

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

104 results

Search Page